BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15494640)

  • 1. Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide.
    Hour TC; Huang CY; Lin CC; Chen J; Guan JY; Lee JM; Pu YS
    Anticancer Drugs; 2004 Sep; 15(8):779-85. PubMed ID: 15494640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of human papillomavirus E6/E7 oncogene by arsenic trioxide in cervical carcinoma cells.
    Um SJ; Lee SY; Kim EJ; Myoung J; Namkoong SE; Park JS
    Cancer Lett; 2002 Jul; 181(1):11-22. PubMed ID: 12430174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of arsenic trioxide on proliferation and metastasis of drug-resistant human ovarian carcinoma cell line].
    Huang SG; Kong BH; Ma YY; Jiang S
    Ai Zheng; 2002 Aug; 21(8):863-7. PubMed ID: 12478894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of hTERT: an important As2O3 induced mechanism of apoptosis in myelodysplastic syndrome.
    Xu W; Wang Y; Tong H; Qian W; Jin J
    PLoS One; 2014; 9(11):e113199. PubMed ID: 25415199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway.
    Sahara N; Takeshita A; Kobayashi M; Shigeno K; Nakamura S; Shinjo K; Naito K; Maekawa M; Horii T; Ohnishi K; Kitamura K; Naoe T; Hayash H; Ohno R
    Leuk Lymphoma; 2004 May; 45(5):987-95. PubMed ID: 15291359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor efficacy of DMSA modified Fe3O4 magnetic nanoparticles combined with arsenic trioxide and adriamycin in Raji cells.
    Cai X; Cai X; Wang C; Chen B; Hua W; Shen F; Yu L; He Z; Shi Y; Chen Y; Xia G; Bao W; Zhang Y; Wang X
    J Biomed Nanotechnol; 2014 Feb; 10(2):251-61. PubMed ID: 24738333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity of arsenic trioxide to transitional carcinoma cells.
    Pu YS; Hour TC; Chen J; Huang CY; Guan JY; Lu SH
    Urology; 2002 Aug; 60(2):346-50. PubMed ID: 12137851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.
    Tabellini G; Cappellini A; Tazzari PL; Falà F; Billi AM; Manzoli L; Cocco L; Martelli AM
    J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.
    Momeny M; Zakidizaji M; Ghasemi R; Dehpour AR; Rahimi-Balaei M; Abdolazimi Y; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH
    Med Oncol; 2010 Sep; 27(3):833-42. PubMed ID: 19763917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD expression.
    Li X; Ding X; Adrian TE
    Pancreas; 2003 Aug; 27(2):174-9. PubMed ID: 12883267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
    Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
    Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells.
    Ramos AM; Fernández C; Amrán D; Sancho P; de Blas E; Aller P
    Blood; 2005 May; 105(10):4013-20. PubMed ID: 15665116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study of the in vitro growth inhibition of human bladder cancer cell line BIU-87 by arsenic trioxide.
    Tong Q; Zeng F; Zhu Z; Lu G
    J Tongji Med Univ; 2000; 20(2):112-5. PubMed ID: 12845720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Concentration Arsenic Trioxide Inhibits Skeletal Myoblast Cell Proliferation via a Reactive Oxygen Species-Independent Pathway.
    Liu SH; Yang RS; Yen YP; Chiu CY; Tsai KS; Lan KC
    PLoS One; 2015; 10(9):e0137907. PubMed ID: 26359868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
    Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
    J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
    Zheng T; Yin D; Lu Z; Wang J; Li Y; Chen X; Liang Y; Song X; Qi S; Sun B; Xie C; Meng X; Pan S; Liu J; Jiang H; Liu L
    Mol Cancer; 2014 May; 13():133. PubMed ID: 24884809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.
    Wang H; Gao P; Zheng J
    Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
    Maeda H; Hori S; Ohizumi H; Segawa T; Kakehi Y; Ogawa O; Kakizuka A
    Cell Death Differ; 2004 Jul; 11(7):737-46. PubMed ID: 15002036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatible arsenic trioxide nanoparticles induce cell cycle arrest by p21(WAF1/CIP1) expression via epigenetic remodeling in LNCaP and PC3 cell lines.
    Jadhav V; Ray P; Sachdeva G; Bhatt P
    Life Sci; 2016 Mar; 148():41-52. PubMed ID: 26883975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.